DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 36.036
EU - Europa 19.539
AS - Asia 19.321
SA - Sud America 3.002
Continente sconosciuto - Info sul continente non disponibili 732
AF - Africa 395
OC - Oceania 66
Totale 79.091
Nazione #
US - Stati Uniti d'America 35.265
FI - Finlandia 8.425
SG - Singapore 7.266
CN - Cina 4.715
DE - Germania 2.986
BR - Brasile 2.313
IT - Italia 2.277
VN - Vietnam 2.136
UA - Ucraina 1.674
HK - Hong Kong 1.606
TR - Turchia 1.116
GB - Regno Unito 1.058
RU - Federazione Russa 787
FR - Francia 676
BD - Bangladesh 563
JP - Giappone 512
SE - Svezia 417
PL - Polonia 378
IN - India 353
CA - Canada 330
MX - Messico 308
ID - Indonesia 266
AR - Argentina 228
NL - Olanda 181
IQ - Iraq 131
ZA - Sudafrica 127
EC - Ecuador 123
BE - Belgio 117
ES - Italia 106
PK - Pakistan 90
CO - Colombia 87
VE - Venezuela 77
LT - Lituania 67
PH - Filippine 64
SA - Arabia Saudita 62
MA - Marocco 60
IE - Irlanda 58
UZ - Uzbekistan 58
AU - Australia 56
MY - Malesia 54
AT - Austria 44
CL - Cile 43
KE - Kenya 41
PE - Perù 41
PY - Paraguay 41
TN - Tunisia 39
CZ - Repubblica Ceca 38
CH - Svizzera 35
RO - Romania 32
AE - Emirati Arabi Uniti 30
DK - Danimarca 29
KR - Corea 28
JM - Giamaica 27
TH - Thailandia 27
IL - Israele 26
IR - Iran 26
NP - Nepal 26
CR - Costa Rica 25
EG - Egitto 25
BO - Bolivia 24
DZ - Algeria 20
AZ - Azerbaigian 19
JO - Giordania 18
OM - Oman 17
DO - Repubblica Dominicana 15
ET - Etiopia 15
GR - Grecia 15
MD - Moldavia 15
SK - Slovacchia (Repubblica Slovacca) 15
HN - Honduras 14
KG - Kirghizistan 14
LB - Libano 14
LV - Lettonia 14
UY - Uruguay 14
AL - Albania 13
HR - Croazia 13
TW - Taiwan 13
BG - Bulgaria 12
PS - Palestinian Territory 12
AO - Angola 11
EU - Europa 11
KZ - Kazakistan 11
PT - Portogallo 11
PA - Panama 10
SN - Senegal 10
TT - Trinidad e Tobago 10
RS - Serbia 9
BB - Barbados 8
HU - Ungheria 8
BH - Bahrain 7
GY - Guiana 7
AM - Armenia 6
NG - Nigeria 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
XK - ???statistics.table.value.countryCode.XK??? 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
CI - Costa d'Avorio 5
EE - Estonia 5
Totale 78.265
Città #
Helsinki 7.919
Singapore 4.483
Ashburn 3.836
Fairfield 3.222
Woodbridge 3.032
San Jose 2.216
Houston 2.146
Jacksonville 1.835
Chandler 1.735
Ann Arbor 1.605
Hong Kong 1.568
Santa Clara 1.550
Beijing 1.359
Wilmington 1.204
Seattle 1.185
Cambridge 942
Ho Chi Minh City 715
Munich 696
Izmir 690
Ferrara 573
Los Angeles 544
Nanjing 533
Hanoi 524
Dallas 485
Tokyo 475
New York 448
Princeton 441
Lauterbourg 378
Council Bluffs 342
Warsaw 332
Boardman 308
San Diego 294
São Paulo 242
Milan 226
Shanghai 219
Addison 209
Mexico City 195
Buffalo 179
Jakarta 167
Chicago 153
Nanchang 151
Shenyang 146
London 139
Dearborn 135
Orem 134
Tianjin 128
Bremen 115
Hefei 114
Turku 114
Da Nang 107
Hebei 107
Frankfurt am Main 106
Toronto 104
Brooklyn 103
Rome 102
Jiaxing 96
Brussels 95
Moscow 93
Changsha 88
Montreal 87
Manchester 86
Redwood City 86
Atlanta 84
Chennai 81
Denver 78
The Dalles 77
Haiphong 74
Nuremberg 69
Rio de Janeiro 69
San Francisco 69
Mountain View 68
Norwalk 67
Amsterdam 66
Johannesburg 65
Boston 64
Bologna 61
Guangzhou 61
Zhengzhou 59
Stockholm 58
Falls Church 57
Jinan 57
Baghdad 56
Dong Ket 56
Phoenix 56
Falkenstein 54
Tashkent 52
Brasília 51
Poplar 49
Columbus 48
San Mateo 48
Quito 46
Hải Dương 43
Kunming 43
Mumbai 42
Ningbo 41
Curitiba 38
Hangzhou 38
Washington 38
Belo Horizonte 37
Dublin 37
Totale 53.798
Nome #
A new luciferase target to the extracellular surface of the plasma membrane reveals a new pathway for ATP release in live intact cells. 2.237
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 2.161
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.081
A role for calcium in Bcl-2 action? 2.033
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 479
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 423
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 375
Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase 363
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 359
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 334
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 328
P2X7 targeting inhibits growth of human mesothelioma 310
IL PROCESSO INFIAMMATORIO 292
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 290
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 290
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 283
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 282
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 271
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 266
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells 264
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 264
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 261
ATP-mediated cytotoxicity in microglial cells 256
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 256
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 255
Expression of P2X7 receptor increases in vivo tumor growth 251
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 248
Role of P2X7 receptor in host response to melanoma 247
Intracellular signalling in Te85 osteosarcoma cells expressing P2X7R isoforms A and B 244
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 243
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 242
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 241
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 237
Purinergic signaling in the immune system 235
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 234
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 233
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 232
Antibiotics and natural peptides as modulators of P2X7 functions 229
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis 229
ATP receptors and giant cell formation 228
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 228
The P2X7 receptor : from ion channel to oncogene 228
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 225
The P2X7 Receptor in Infection and Inflammation 224
Blockade of P2X7 receptor inhibits formation of multinucleated giant cells. 223
Insight on P2X7 receptor role as oncogene 223
Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis 223
Extracellular nucleotides and nucleosides as signalling molecules 223
P2X7 receptor as key modulator of PI3K/HIF1a/GSK3b metabolic pathway in neuroblastoma 222
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 221
Human primary keratinocytes express functional P2 receptors whose expression is modulated by inflammatory cytokines. 220
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 219
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice 219
The antibiotic polymyxin B modulates P2X7 receptor function 218
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 218
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 217
A defect in glycogen synthesis characterizes insulin resistance in hypertensive patients with type 2 diabetes 217
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 217
Purinoceptor function in the immune system 216
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 215
The P2X7 receptor is a key modulator of aerobic glycolysis. 213
Acute myeloid leukaemia:analysis of the expression of P2X7a and P2X7B isoforms 213
Dysfunctional inflammasome in Schnitzler's syndrome 213
P2X7 contemporarily impacts melanoma growth and anti-melanoma defense 212
Inhibitory effect of P2X7 receptor antagonists on in vivo tumor growth 212
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 211
The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner 210
The P2X7 receptor: A main player in inflammation 210
Human keratinocytes express functional P2 receptors whose expression is modulated by inflammatory cytokines. 210
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 209
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 208
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 207
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 207
Analysis of Chlamydia and Mycoplasma Expression in Atherosclerotic plaques and its Relation with P2X7 and TLR Expression 207
Altered IL-1ß secretion in a patient affected by Schnitzler's syndrome 205
The antibiotic polymyxin B modulates P2X7 receptor function 205
P2 receptors in cancer progression and metastatic spreading 204
Extracellular purines, purinergic receptors and tumor growth 204
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 203
Defective P2Y purinergic receptor function induces impaired glucose transport in type 2 diabetes. 203
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors 202
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 202
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 201
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 200
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 200
The P2X7 receptor: a key player in IL-1 processing and release 200
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 200
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells 200
A ROLE FOR P2X7 RECEPTORS IN MICROGLIA PROLIFERATION 199
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 199
Alerting and tuning the immune response by extracellular nucleotides 199
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 199
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 199
ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival 199
In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe 197
Detection of extracellular ATP in the tumor microenvironment, using the pmeLUC biosensor 197
Apoptosis is dependent on intracellular zinc and independent of intracellular calcium in lymphocytes 196
Role of P2X7 polymorphisms in idiopathic infertility and HHV-6A infection 196
Calcium and apoptosis: facts and hypotheses 196
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 196
Totale 31.145
Categoria #
all - tutte 327.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.919
Totale 335.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.501 123 468 260 157 278 213 237 250 197 356 434 1.528
2022/20234.150 486 173 139 487 685 598 123 447 540 53 280 139
2023/20242.128 235 314 91 62 189 262 91 145 47 49 93 550
2024/20259.632 266 276 718 359 1.146 1.019 420 624 1.616 1.015 1.147 1.026
2025/202633.618 2.528 1.032 2.157 3.312 3.794 1.534 3.131 1.588 9.938 2.783 1.128 693
2026/2027643 643 0 0 0 0 0 0 0 0 0 0 0
Totale 79.091